143 related articles for article (PubMed ID: 20107154)
1. The therapeutic response and clinical outcome of adults with ALL1(MLL)/AF4 fusion positive acute lymphoblastic leukemia according to the GIMEMA experience.
Cimino G; Cenfra N; Elia L; Sica S; Luppi M; Meloni G; Vignetti M; Paoloni F; Foà R; Mandelli F
Haematologica; 2010 May; 95(5):837-40. PubMed ID: 20107154
[TBL] [Abstract][Full Text] [Related]
2. Pre-pre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission.
Janssen JW; Ludwig WD; Borkhardt A; Spadinger U; Rieder H; Fonatsch C; Hossfeld DK; Harbott J; Schulz AS; Repp R
Blood; 1994 Dec; 84(11):3835-42. PubMed ID: 7949140
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study.
Vey N; Thomas X; Picard C; Kovascovicz T; Charin C; Cayuela JM; Dombret H; Dastugue N; Huguet F; Bastard C; Stamatoulas A; Giollant M; Tournilhac O; Macintyre E; Buzyn A; Bories D; Kuentz M; Dreyfus F; Delannoy A; Raynaud S; Gratecos N; Bordessoule D; de Botton S; Preudhomme C; Reman O; Troussard X; Pigneux A; Bilhou C; Vernant JP; Boucheix C; Gabert J;
Leukemia; 2006 Dec; 20(12):2155-61. PubMed ID: 17039234
[TBL] [Abstract][Full Text] [Related]
4. Favorable outcome in non-infant children with MLL-AF4-positive acute lymphoblastic leukemia: a report from the Tokyo Children's Cancer Study Group.
Tomizawa D; Kato M; Takahashi H; Fujimura J; Inukai T; Fukushima T; Kiyokawa N; Koh K; Manabe A; Ohara A
Int J Hematol; 2015 Nov; 102(5):602-10. PubMed ID: 26410102
[TBL] [Abstract][Full Text] [Related]
5. Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome.
Cimino G; Elia L; Mancini M; Annino L; Anaclerico B; Fazi P; Vitale A; Specchia G; Di Raimondo F; Recchia A; Cuneo A; Mecucci C; Pane F; Saglio G; Foa R; Mandelli F;
Blood; 2003 Sep; 102(6):2014-20. PubMed ID: 12791662
[TBL] [Abstract][Full Text] [Related]
6. The heterodimerization domains of MLL-FYRN and FYRC--are potential target structures in t(4;11) leukemia.
Pless B; Oehm C; Knauer S; Stauber RH; Dingermann T; Marschalek R
Leukemia; 2011 Apr; 25(4):663-70. PubMed ID: 21233834
[TBL] [Abstract][Full Text] [Related]
7. A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study.
Chiaretti S; Vitale A; Vignetti M; Piciocchi A; Fazi P; Elia L; Falini B; Ronco F; Ferrara F; De Fabritiis P; Luppi M; La Nasa G; Tedeschi A; Califano C; Fanin R; Dore F; Mandelli F; Meloni G; Foà R
Haematologica; 2016 Dec; 101(12):1544-1552. PubMed ID: 27515250
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation.
Uckun FM; Herman-Hatten K; Crotty ML; Sensel MG; Sather HN; Tuel-Ahlgren L; Sarquis MB; Bostrom B; Nachman JB; Steinherz PG; Gaynon PS; Heerema N
Blood; 1998 Aug; 92(3):810-21. PubMed ID: 9680349
[TBL] [Abstract][Full Text] [Related]
9. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
Spinelli O; Peruta B; Tosi M; Guerini V; Salvi A; Zanotti MC; Oldani E; Grassi A; Intermesoli T; Micò C; Rossi G; Fabris P; Lambertenghi-Deliliers G; Angelucci E; Barbui T; Bassan R; Rambaldi A
Haematologica; 2007 May; 92(5):612-8. PubMed ID: 17488684
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4; 11)(q21; q23).
Hilden JM; Frestedt JL; Moore RO; Heerema NA; Arthur DC; Reaman GH; Kersey JH
Blood; 1995 Nov; 86(10):3876-82. PubMed ID: 7579356
[TBL] [Abstract][Full Text] [Related]
11. AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).
Taki T; Kano H; Taniwaki M; Sako M; Yanagisawa M; Hayashi Y
Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14535-40. PubMed ID: 10588740
[TBL] [Abstract][Full Text] [Related]
12. LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia.
von Bergh AR; Beverloo HB; Rombout P; van Wering ER; van Weel MH; Beverstock GC; Kluin PM; Slater RM; Schuuring E
Genes Chromosomes Cancer; 2002 Sep; 35(1):92-6. PubMed ID: 12203795
[TBL] [Abstract][Full Text] [Related]
13. Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment.
Jung R; Jacobs U; Krumbholz M; Langer T; Keller T; De Lorenzo P; Valsecchi MG; van der Velden VH; Moericke A; Stanulla M; Teigler-Schlegel A; Panzer-Gruemayer ER; van Dongen JJ; Schrappe M; den Boer ML; Pieters R; Rascher W; Metzler M
Leukemia; 2010 Apr; 24(4):903-7. PubMed ID: 20164851
[No Abstract] [Full Text] [Related]
14. Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan Infant Leukemia Study Group.
Tomizawa D; Koh K; Hirayama M; Miyamura T; Hatanaka M; Saikawa Y; Ishii E
Pediatr Blood Cancer; 2009 Jul; 52(7):808-13. PubMed ID: 19229974
[TBL] [Abstract][Full Text] [Related]
15. A novel MLL/AF4 fusion gene lacking the AF4 transactivating domain in infant acute lymphoblastic leukemia.
Pane F; Intrieri M; Izzo B; Quintarelli C; Vitale D; Migliorati R; Sebastio L; Salvatore F
Blood; 2002 Dec; 100(12):4247-8. PubMed ID: 12433702
[No Abstract] [Full Text] [Related]
16. Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation.
Kosaka Y; Koh K; Kinukawa N; Wakazono Y; Isoyama K; Oda T; Hayashi Y; Ohta S; Moritake H; Oda M; Nagatoshi Y; Kigasawa H; Ishida Y; Ohara A; Hanada R; Sako M; Sato T; Mizutani S; Horibe K; Ishii E
Blood; 2004 Dec; 104(12):3527-34. PubMed ID: 15297313
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of S100A6 induces GVL effects in MLL/AF4-positive ALL in human PBMC-SCID mice.
Tamai H; Miyake K; Yamaguchi H; Shimada T; Dan K; Inokuchi K
Bone Marrow Transplant; 2014 May; 49(5):699-703. PubMed ID: 24583627
[TBL] [Abstract][Full Text] [Related]
18. Secondary acute myeloid leukemia with translocation (4;11) and MLL/AF4 rearrangement in a 15-year-old boy treated for common acute lymphoblastic leukemia 11 years earlier.
Blütters-Sawatzki R; Borkhardt A; Grathwohl J; Repp R; Rheinisch-Becker I; Bohle RM; Lampert F
Ann Hematol; 1995 Jan; 70(1):31-5. PubMed ID: 7827204
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of a rare MLL-AF4 (MLL-AFF1) fusion rearrangement in infant leukemia.
Bizarro S; Cerveira N; Correia C; Lisboa S; Peixoto A; Norton L; Teixeira MR
Cancer Genet Cytogenet; 2007 Oct; 178(1):61-4. PubMed ID: 17889710
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.
Sanjuan-Pla A; Bueno C; Prieto C; Acha P; Stam RW; Marschalek R; Menéndez P
Blood; 2015 Dec; 126(25):2676-85. PubMed ID: 26463423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
